Cannabis Sativa Inc (OTCMKTS: CBDS) Set To Trend Higher

Last week, my colleague Jarrod Wesson took a look at Cannabis Sativa Inc (OTCMKTS:CBDS) and placed it on our watchlist. As I take a look at the company this week, I believe it's set to start trending higher. Here's what I'm looking at.The stock is trading off of the low made from the retracement from the high of $9.50 made on the last major spike. CBDS retraced to a low of $5.50 on March 3, 2017. It has since consolidated and is now trading at $6.05 with good volume. From a technical analysis perspective, this is a dip in an uptrend that commenced back in mid-March of 2017. This uptrend is a reflection of the constructive business activities over the last year that the company continues to reap positive results from.For those of you not familiar with Cannabis Sativa, the company is a web retail company that focuses on the sale of CBD products – water, snacks, that sort of thing. The company has recently acquired iBudtender, a company that has developed an application that has the potential to become the Yelp of the medicinal and recreational marijuana space.Ibudtender is a comprehensive medical cannabis resource. Patients can find cannabis medication based on their needs and preferences and medicate safely knowing exactly what is in their medicine and how to use it properly and safely. Our one-of-a-kind system connects patients, dispensaries, businesses and providers together not just socially, but commercially and personally as well. The same product a provider adds to the system can be found and shared by patients, doctors, advocates and investors as well as added to dispensary menus creating a cycle of knowledge and awareness. Ibudtender wants to help make the medical cannabis industry a safer one for all to benefit from and grow upon.On March 24, 2017, Cannabis Sativa announced that iBudtender will unveil its new APP this weekend at HempCon, Heart of Nature Fest, taking place at the Sonoma County Fairgrounds in Santa Rosa, California on March 24 – 26. Heart of Nature is a medical marijuana show catering to those who may benefit from the medical use of marijuana. At the show there were Medical marijuana dispensaries, collectives, caregivers, evaluation services, legal services, educational institutions, equipment, accessories, and live entertainment. Heart of Nature’s educational events included seminars and presentations by industry leaders, advocates, and attorneys. Attendees were invited to stop at the iBudtender booth to check out the new APP.

We believe contains the highest standards in product safety for cannabis patients of any existing app, said Cannabis Sativa President David Tobias.

The Ibudtender APP features patient reviews, nutritional information, directions, warnings, local availability and more. Consumers can find a product based on your preferences, needs, symptoms or conditions, then order it locally for pickup or delivery.Business owners were encouraged to visit the iBudtender booth and sign up to preview the iBudtender business platform for dispensaries, delivery services and Manufacturers, for a no obligation 30 day trial period. The B2B platform is designed to increase business as well as promote data sharing in an effort to help patients find the best and most effective products.As for the financials of Cannabis Sativa, fourth quarter financials for 2016 are yet to be reported. The company does show steady revenues, albeit relatively small scale wise. Revenues should begin to increase as the iBudtender app acquires more signup and becomes more mainstream in the cannabis sphere. The company’s current market capitalization comes in at $116.20 million, on 19.21 million shares outstanding as of April 06, 2017The iBudtender app is very well designed, comprehensive, and useful for both cannabis consumers, and business. The only thing missing is the large number of users. That number will grow, and as it does it will have a positive impact on the value of the company, and CBDS stock should continue on its uptrend. We will be updating our subscribers as soon as we know more. For the latest updates on CBDS, sign up below!Disclosure: We have no position in CBDS and have not been compensated for this article.